GROW
U.S. Global Investors, Inc.
There isn't enough reported data to score GROW yet.
GS
The Goldman Sachs Group, Inc.
GS's fundamentals are strong: revenue grew 19% and its operating margin rose 4 points to 40%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
GROW Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
GROW's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like GROW.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
GROW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4x | $0.52 | -79% |
| Fair | 13x | $1.68 | -33% |
| Current | 19x | $2.52 | — |
| Expensive | 35x | $4.53 | +80% |
Historical ranges are pointers, not guarantees.
GROW's PE is 19x, but its earnings don't support one, so it isn't a reliable read right now.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS has the edge over GROW in the historical PE scenario, which offers more potential upside but is not a forecast.
GROW Forward outlook
There aren't enough analyst estimates for GROW to show an outlook.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
GROW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.13 | +86% |
| Q2 2026 | $0.24 | +$0.27 |
| Q1 2026 | $0.25 | +$0.26 |
| Q4 2025 | $0.01 | -50% |
| Q3 2025 | $0.07 | -42% |
| Q2 2025 | -$0.03 | -133% |
| Q1 2025 | -$0.01 | -108% |
| Q4 2024 | $0.02 | -91% |
GROW's earnings per share have fallen from their peak: $0.13 over the past year, against $2.15 in late 2021.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over GROW on earnings, with more consistent year-over-year improvement.
GROW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +18% |
| Q2 2026 | $2.7M | +39% |
| Q1 2026 | $2.8M | +31% |
| Q4 2025 | $2.5M | +13% |
| Q3 2025 | $2.3M | +4.4% |
| Q2 2025 | $2M | -20% |
| Q1 2025 | $2.1M | -19% |
| Q4 2024 | $2.2M | -21% |
GROW's revenue is recovering but still below its 2021 peak: $3M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.1% | +25 points |
| Q2 2026 | -3.2% | +48 points |
| Q1 2026 | 3.2% | +46 points |
| Q4 2025 | -3.5% | +21 points |
| Q3 2025 | -23% | +3 points |
| Q2 2025 | -51% | -35 points |
| Q1 2025 | -42% | -24 points |
| Q4 2024 | -24% | -31 points |
GROW's operating margin was 2.1% last quarter, up 25 points from the same quarter a year ago.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over GROW on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS has the edge over GROW on profitability, with a higher operating margin.
GROW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $483K | +$515K |
| Q2 2026 | $203K | +$218K |
| Q1 2026 | $275K | +$699K |
| Q3 2025 | -$32K | -300% |
| Q2 2025 | -$15K | -115% |
| Q1 2025 | -$424K | -$299K |
| Q4 2024 | -$406K | -$380K |
| Q3 2024 | $16K | -98% |
GROW has the stronger cash trend. Its trailing FCF is down 72% versus its history, compared with GS at down 278%.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
GROW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.8% | -360K shares |
| 1 year | -5% | -648K shares |
| 3 years | -15% | -2.1M shares |
| 5 years | -18% | -2.7M shares |
| Available history | -19% | -2.8M shares |
GROW has the edge over GS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $320,000 |
| Q2 2026 | $364,000 |
| Q1 2026 | $552,000 |
| Q4 2025 | $666,000 |
| Q3 2025 | $390,000 |
| Q2 2025 | $395,000 |
| Q1 2025 | $453,000 |
| Q4 2024 | $591,000 |
GROW spent $2M buying back its own shares over the past year, up 4% from the year before.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has 301M diluted shares, down 4.4% from a year ago, with $15B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
GROW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2,691.6x | Net Cash |
| Q1 2024 | -61.7x | Net Cash |
| Q4 2023 | -16.3x | Net Cash |
| Q3 2023 | -11.2x | Net Cash |
| Q2 2023 | -6.7x | Net Cash |
| Q1 2023 | -4.0x | Net Cash |
| Q4 2022 | -2.9x | Net Cash |
| Q3 2022 | -2.3x | Net Cash |
GROW has the edge over GS on leverage, with a lower net debt burden relative to earnings.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like GS.
GROW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.3 | Neutral |
| Stochastic | 6.4 | Oversold |
GROW's weekly RSI is 38 (neutral) and its Stochastic is 6 (oversold).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
GROW PE vs Financial Services Sector
| Metric | GROW | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 13x | 49% above |
| PE % | 60 | 63 | 3 pts below |
GROW is trading at 19x earnings, a 49% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS has the edge over GROW on valuation relative to its sector.
GROW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.72 | 7.4% below |
| 20 week MA | $2.92 | 14% below |
| 50 week MA | $2.84 | 11% below |
| 100 week MA | $2.62 | 3.8% below |
| 200 week MA | $2.68 | 6% below |
GROW is in a downtrend: it's below all five of its weekly moving averages, and 6% below its 200-week average.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS has the edge over GROW on trend strength, trading above more of its moving averages.
GROW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.33 | $4.62 | +247% |
| 2021 | $4.62 | $4.55 | -1.5% |
| 2022 | $4.55 | $2.65 | -42% |
| 2023 | $2.65 | $2.82 | +6.4% |
| 2024 | $2.82 | $2.45 | -13% |
| 2025 | $2.45 | $2.47 | +0.8% |
| 2026 YTD | $2.47 | $2.52 | +2% |
GROW has the edge over GS on returns for 2026, with the stronger performance.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.